Inside the ACHIEVE Trial: Do Hearing Aids Protect the Brain?

Few questions in hearing research draw as much attention as the link between hearing loss and thinking skills. A handful of landmark studies define what we know — and what we still don't.

Where the Evidence Began

A 2013 paper from Frank Lin's team at Johns Hopkins, published in JAMA Internal Medicine, followed 1,984 older adults for six years. Those with hearing loss declined cognitively 30–40% faster than participants with normal hearing.

The authors were careful with their language: this was an observational association. Nothing in the design could separate cause from effect — or rule out shared factors driving both conditions.

Three Working Theories

Science offers a few candidate explanations for how hearing loss could feed cognitive change:

What ACHIEVE Tested

The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) trial, led from Johns Hopkins and published in The Lancet in 2023, is the flagship randomized attempt to answer the question directly: does treating hearing loss slow cognitive decline?

The headline results:

The Lancet Commission's Position

The 2020 Lancet Commission report on dementia prevention rated hearing loss the largest modifiable dementia risk factor — implicated in roughly 8% of cases worldwide. Its recommendation: treat hearing loss as one pillar of a broader dementia-risk strategy.

The Practical Takeaway

Tempting as the headline is, no trial has proven that hearing treatment prevents dementia. The evidence supports an association with a plausible biological story, and individual results differ.

Where experts do agree: treating hearing loss measurably improves communication, social connection, and daily quality of life — benefits worth having with or without any cognitive upside.

This article is for informational purposes only. For concerns about hearing loss or cognitive health, consult a licensed healthcare provider.